Skip to content

Pulsar-18 T3 7/100/135Recalls & reported problems

Biotronik AG · Class 3 · Implant

All models of Pulsar-18 T3 (52)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07640130447103), received between Dec 20, 2022 and Dec 20, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Difficult to Remove” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Difficult to Remove1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 20, 2022Difficult to Remove; Difficult to Remove

    A PULSAR-18 T3 SELF-EXPANDABLE STENT SYSTEM WAS SELECTED FOR TREATMENT. IT WAS POSSIBLE TO IMPLANT THE STENT, BUT DIFFICULTIES WERE NOTICED DURING IMPLANTATION AND WITHDRAWAL. DATE OF EVENT UNKNOWN.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16019889 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page